Tamoxifen Completed Phase 2 Trials for Urinary Bladder Neoplasms Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00710970Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment